[Neutrophils and cancer: discovery of a new mechanism of cellular toxicity and therapeutic perspectives].
作者信息
Victoor Camille, Dubois Bertrand
机构信息
Master 1 cancer, module d'immunologie-virologie, université de Lyon, université Claude Bernard Lyon 1, Lyon, France.
Inserm 1052, CNRS 5286, centre Léon Bérard, centre de recherche en cancérologie de Lyon, 28 rue Laennec, 69373 Lyon cedex 08, France.
出版信息
Med Sci (Paris). 2020 Jan;36(1):80-82. doi: 10.1051/medsci/2019262. Epub 2020 Feb 4.
PMID:32014104
Abstract
摘要
相似文献
1
[Neutrophils and cancer: discovery of a new mechanism of cellular toxicity and therapeutic perspectives].
Med Sci (Paris). 2020 Jan;36(1):80-82. doi: 10.1051/medsci/2019262. Epub 2020 Feb 4.
2
[TGF-β-targeted immunotherapy aiming for new and efficient treatments of cancer].
Med Sci (Paris). 2020 Jan;36(1):77-79. doi: 10.1051/medsci/2019261. Epub 2020 Feb 4.
3
Innovative and propagable translational research model established for cell-based therapy at Chinese PLA General Hospital.
Sci China Life Sci. 2016 Oct;59(10):1063-1067. doi: 10.1007/s11427-015-4869-5.
4
Celyad's novel CAR T-cell therapy for solid malignancies.
Curr Res Transl Med. 2018 May;66(2):53-56. doi: 10.1016/j.retram.2018.03.001. Epub 2018 Apr 4.
5
[New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge].
Med Sci (Paris). 2017 Jun-Jul;33(6-7):563-564. doi: 10.1051/medsci/20173306001. Epub 2017 Jul 19.
6
Preface: More than two decades of modern tumor immunology.
Methods Enzymol. 2019;629:xxi-xl. doi: 10.1016/S0076-6879(19)30459-8.
7
Human Vaccines & Immunotherapeutics: News.
Hum Vaccin Immunother. 2018;14(8):1834-1835. doi: 10.1080/21645515.2018.1507373.
8
Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal.
J Natl Compr Canc Netw. 2018 Jul;16(7):903-908. doi: 10.6004/jnccn.2018.7040.
9
Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy.
Adv Healthc Mater. 2016 May;5(9):1088-93. doi: 10.1002/adhm.201500998. Epub 2016 Mar 17.
10
[Non-mutated neoantigens, TEIPP, as new targets for cancer immunotherapies].
Med Sci (Paris). 2020 Jan;36(1):83-86. doi: 10.1051/medsci/2019263. Epub 2020 Feb 4.
Zotero 插件